Unusual Manifestation of Toscana Virus Infection, Spain by Sanbonmatsu-Gámez, Sara et al.
LETTERS
Keith P. Klugman, Christina 
Mills Astley, and Marc Lipsitch
Author afﬁ  liations: Emory University, Atlanta, 
Georgia, USA (K.P. Klugman); University of 
Witwatersrand, Johannesburg, South Africa 
(K.P. Klugman); Harvard School of Public 
Health, Boston, Massachusetts, USA (C.M. 
Astley, M. Lipsitch); and Children’s Hospi-
tal, Boston (C.M. Astley)
DOI: 10.3201/eid1502.081208
References
    1.    Brundage JF, Shanks GD. Deaths from 
bacterial pneumonia during 1918–19 
inﬂ   uenza pandemic. Emerg Infect 
Dis. 2008;14:1193–9. DOI: 10.3201/
eid1408.071313
  2.   Mills CE, Robins JM, Lipsitch M. Trans-
missibility of 1918 pandemic inﬂ  uenza. 
Nature. 2004;432:904–6. DOI: 10.1038/
nature03063
    3.   Klugman KP, Madhi SA. Pneumococ-
cal vaccines and ﬂ   u preparedness. Sci-
ence. 2007;316:49–50. DOI: 10.1126/
science.316.5821.49c
    4.    Tilghman RC, Finland M. Clinical sig-
niﬁ   cance of bacteremia in pneumo-
coccal pneumonia. Arch Intern Med. 
1937;59:602–19.
  5.   Morens DM, Taubenberger JK, Fauci AS. 
Predominant role of bacterial pneumonia 
as a cause of death in pandemic inﬂ  uenza: 
implications for pandemic inﬂ  uenza pre-
paredness. J Infect Dis. 2008;198:962–70. 
DOI: 10.1086/591708
Address for correspondence: Keith P. Klugman, 
Rollins School of Public Health, Emory 
University, 1518 Clifton Rd NE, Atlanta, GA 
30322, USA; email: keith.klugman@emory.edu
Unusual 
Manifestation of 
Toscana Virus 
Infection, Spain
To the Editor: Toscana virus 
(TOSV) causes acute meningitis and 
meningoencephalitis in Mediterra-
nean countries (1). In Spain, neurolog-
ic TOSV infection has been reported 
since 1988. All cases have been self-
limited aseptic meningitis (2). Since 
2003, we have routinely investigated 
TOSV in cerebrospinal ﬂ  uid  (CSF) 
specimens from patients with suspect-
ed viral meningitis and encephalitis 
by using cell culture and reverse tran-
scription–PCR (RT-PCR) (3,4). Also, 
as part of a regional project (05/305, 
Consejería de Salud, Junta de Anda-
lucía, Spain), we investigated TOSV 
in mild nonneurologic syndromes by 
detection of immunoglobulin (Ig) M 
against TOSV by using enzyme im-
munoassay (Diesse Diagnostica Se-
nese S.p.A, Siena, Italy). From May 
through September of 2006 and 2007, 
a total of 358 serum samples were ran-
domly selected from patients for whom 
microbiologic determinations had 
been requested to investigate febrile 
illnesses.
As a result of these virologic and 
serologic surveys, we detected 7 cases 
of TOSV infection. Mild aseptic men-
ingitis developed in 4 patients; in 3 
patients, the infection had an atypical 
manifestation, as described below.
Patient 1, a 45-year-old man, was 
referred to the Hospital Universitario 
Virgen de las Nieves in September 
2004 with confusion and a temperature 
of 39°C. He had had a splenectomy 20 
years before, and in 2002, he had re-
ceived a kidney transplant after renal 
failure resulting from meningococ-
cemia. On admission, the patient was 
receiving chronic immunosuppressive 
treatment. Ten days after admission, he 
had tonic-clonic seizures. Aphasia and 
paresis developed after an ictus of the 
left hemisphere, and his level of con-
sciousness decreased rapidly. Treat-
ment with corticosteroids was initi-
ated because vasculitis was suspected. 
The patient responded to treatment, 
and 2 months after admission, he was 
discharged. Four months later, he still 
had impaired speech and paresis. Lym-
phocytic pleocytosis, a normal glucose 
level, and elevated protein levels were 
observed in CSF samples taken during 
the 2-month period of hospitalization. 
Bacterial and fungal cultures, as well 
as results of PCR for enterovirus, her-
pes simplex virus (HSV), and varicel-
la-zoster virus (VZV), were negative 
in CSF specimens taken at admission 
and 1 month later. TOSV was detected 
by cell culture and nested RT-PCR 
in both samples (3). Anti-TOSV IgG 
was not detected in serum samples 
obtained on days 1 and 10; 5 months 
later, a borderline result was obtained. 
Anti-TOSV IgM was not detected on 
day 1 but was detected on day 10; 5 
months later, anti-TOSV IgM was 
detected. Sequence analysis of ampli-
ﬁ  ed fragments from L and S segments 
(GenBank accession nos. FJ356705 
and FJ356706, respectively) indicated 
95%–98% homology with sequences 
from Spanish TOSV strains (3) and 
84% homology with Italian reference 
strain ISS Phl.3.
Patient 2, a 54-year-old man, 
was admitted to a regional hospital in 
Granada Province in November 2007. 
He was confused and agitated, and he 
reported having fever and headache 
2 days before. On admission, he was 
receiving treatment with corticoster-
oids for Crohn disease. Analysis of the 
CSF specimen showed lymphocytic 
pleocytosis, a normal glucose level, 
and increased protein levels. Results 
of PCR for HSV, VZV, and enterovi-
rus were negative. TOSV was detected 
in the CSF sample by cell culture and 
real-time RT-PCR (4). The patient was 
treated with antimicrobial drugs and 
acyclovir. He recovered and was dis-
charged 3 weeks after admission. One 
month later, he returned with paresis 
and aphasia, secondary to an ischemic 
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stroke located in the left hemisphere. 
IgG and IgM antibodies against TOSV 
were detected in a serum sample ob-
tained at that time. The patient was 
discharged 1 week later with slight 
aphasia.
The most relevant common signs 
observed in patients 1 and 2 were the 
ischemic complications. Few cases of 
complicated encephalitis with sequelae 
caused by TOSV have been described 
(5,6). Moreover, to our knowledge, 
persistent neurologic TOSV infection 
has not been reported. The immune 
status of these patients probably in-
ﬂ  uenced the clinical outcome in both 
patients and the delayed serologic re-
sponse in patient 1.
Patient 3, a 41-year-old woman, 
sought treatment for exanthema at her 
health care center in July 2004. Test 
results for IgM antibodies against ru-
bella, parvovirus B19, and Rickettsia 
conorii were negative. Speciﬁ  c anti-
TOSV IgM was detected. The infec-
tion was self-limited, and no signs of 
neurologic involvement were associ-
ated with the rash. This was the only 
case of anti-TOSV IgM detection in 
358 serum specimens analyzed from 
patients with nonneurologic syn-
dromes. Although this ﬁ  nding is not 
conclusive, it suggests that TOSV 
infection might be involved occasion-
ally in other mild syndromes. Two 
other cases of TOSV infection without 
neurologic involvement have been re-
ported elsewhere: febrile erythema in 
Italy (7) and an inﬂ  uenza-like illness 
in southern France (8).
The unusual manifestations of 
TOSV infection reported here oc-
curred in persons from rural areas 
within Granada Province, where se-
roprevalence rates have been shown 
to be higher than in urban areas (3). 
These data provide more information 
about this arboviral infection. Atypi-
cal TOSV infection could occur par-
ticularly in areas where the virus is 
endemic.
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Sporadic 
Oropouche Virus
Infection, Acre, 
Brazil
To the Editor: Oropouche virus 
(OROV), a member of the Bunya-
viridae family, Orthobunyavirus ge-
nus, Simbu serogroup, is transmitted 
to humans in urban areas by the bit-
ing midge Culicoides paraensis and 
causes epidemic acute febrile disease 
(1). Since its ﬁ  rst isolation in Trinidad 
in 1955 (2), OROV has been associ-
ated with large outbreaks in South and 
Central America; half a million cases 
have been described during the past 
45 years (1). The tripartite genome of 
OROV comprises single-strand, neg-
ative-sense large (L), medium (M), 
and small (S) RNAs that encode RNA 
polymerase, glycoproteins, and nu-
cleocapsid, respectively. Studies have 
indicated the existence of 3 genotypes 
of OROV circulating in Brazil: geno-
types I and II in the Amazon Basin and 
genotype III in the Southeast Region 
(3–5).
OROV causes explosive urban 
epidemics. Serologic evidence of ex-
posure to OROV in populations not 
affected by known outbreaks suggests 
that the virus circulates endemically 
(1). However, no sporadic infections 
have been reported. Here we report a 
sporadic OROV infection detected by 
clinical and laboratory surveillance of 
acute febrile illnesses in Acre, a state 
in the western Amazon region of Bra-
zil. From March 2004 through Octo-
ber 2006, we prospectively investigat-
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